Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study

Constipation is the most common adverse event (AE) of opioid therapy. This multicenter, phase 2 study evaluated the efficacy and safety of linaclotide in treating opioid-induced constipation (OIC) in patients with chronic noncancer pain syndromes (NCT02270983). Adults with OIC (<3 spontaneous bow...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pain
Main Authors: Brenner, Darren M., Argoff, Charles E., Fox, Susan M., Bochenek, Wieslaw, D'Astoli, Patricia, Blakesley, Rick E., Reasner, David S., O'Dea, Christopher R., Cash, Brooks D.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170446/
https://ncbi.nlm.nih.gov/pubmed/32310620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/j.pain.0000000000001754
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados